Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT04421222
Title Oral EPI-7386 in Patients With Metastatic Castration-Resistant Prostate Cancer (EPI-7386)
Acronym EPI-7386
Recruitment Active, not recruiting
Gender male
Phase Phase I
Variant Requirements No
Sponsors ESSA Pharmaceuticals
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA | CAN

Facility Status City State Zip Country Details
Hematology Oncology Associates of the Treasure Coast Port St. Lucie Florida 34952 United States Details
Winship Cancer Institute of Emory University Atlanta Georgia 30322 United States Details
Massachusetts General Hospital Boston Massachusetts 02215 United States Details
Washington University School of Medicine in St. Louis St. Louis Missouri 63110 United States Details
Comprehensive Cancer Center of NV Las Vegas Las Vegas Nevada 89169 United States Details
Great Lakes Cancer Center Buffalo New York 14203 United States Details
Memorial Sloan Kettering Cancer Center New York New York 10065 United States Details
BC Cancer Vancouver British Columbia V5Z 4E6 Canada Details
Centre hospitalier de l'Université de Montréal Montréal Quebec H2X0A9 Canada Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field